Institute of Biomedical Research Corp.
OTC: MRES0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Drasko D. Pekovic
- Employees
- 7
- Headquarters
- Podgorica, Montenegro
- IPO year
- 2004
- Market cap
- $3.5M
- Website
- https://mrescorp.com
Loading MRES…
Loading profile data…Frequently asked questions about MRES
What does Institute of Biomedical Research Corp. (MRES) do?
Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical prod...
Where does MRES trade?
Institute of Biomedical Research Corp. (MRES) trades on the Other OTC.
What sector is MRES in?
Institute of Biomedical Research Corp. (MRES) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Institute of Biomedical Research Corp.?
Drasko D. Pekovic is the chief executive officer of Institute of Biomedical Research Corp. (MRES).
Where is Institute of Biomedical Research Corp. headquartered?
Institute of Biomedical Research Corp. is headquartered in Montenegro.
Does MRES pay a dividend?
Institute of Biomedical Research Corp. (MRES) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MRES go public?
Institute of Biomedical Research Corp. (MRES) completed its initial public offering in 2004.